Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Durect Corp (DRRX)

Durect Corp (DRRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Durect Corp 10240 BUBB ROAD CUPERTINO CA 95014 USA

www.durect.com Employees: 21 P: 408-777-1417 F: 408-777-3577

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.

Key Statistics

Overview:

Market Capitalization, $K 59,313
Enterprise Value, $K 48,303
Shares Outstanding, K 31,054
Float, K 30,060
% Float 96.80%
Short Volume Ratio 0.61
% of Insider Shareholders 3.20%
% of Institutional Shareholders 28.03%

Financials:

Annual Sales, $ 2,030 K
Annual Net Income, $ -8,320 K
Last Quarter Sales, $ 450 K
Last Quarter Net Income, $ -2,270 K
EBIT, $ -16,730 K
EBITDA, $ -16,650 K

Growth:

1-Year Return 27.33%
3-Year Return -68.69%
5-Year Return -89.68%
5-Year Revenue Growth -93.13%
5-Year Earnings Growth 51.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 08/12/25
Next Earnings Date 11/12/25
Earnings Per Share ttm -0.40
EPS Growth vs. Prev Qtr 46.15%
EPS Growth vs. Prev Year 41.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/06/22

DRRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -259.16%
Return-on-Assets % -71.78%
Profit Margin % -409.85%
Debt/Equity 0.00
Price/Sales 29.51
Price/Cash Flow N/A
Price/Book 17.02
Book Value/Share 0.11
Interest Coverage -0.76
60-Month Beta 0.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar